Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors

NCT00003460 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Childhood CNS Primitive Neuroectodermal Tumor

Interventions

DRUG: Antineoplaston therapy (Atengenal + Astugenal)

Sponsor

Burzynski Research Institute